Alebund Pharmaceuticals’ AP301 NDA Accepted for Review by China’s NMPA

Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, announced that the New Dr...

August 11, 2026 | Tuesday | News
Innovent Biologics to Commercialize Daiichi Sankyo’s Vanflyta in China

Collaboration to accelerate access to Vanflyta® for patients with newly diagnosed FLT3-ITD positive AML Innovent Biologics, Inc. (01801.HK) and ...

August 11, 2026 | Tuesday | News
Leads Biolabs Advances Phase II Study of Opamtistomig Combination Therapy for First-Line Liver Cancer

Nanjing Leads Biolabs Co., Ltd. announced that its Phase II clinical study evaluating Opamtistomig (LBL-024), a proprietary PD-L1/4-1BB bispecific antibo...

August 07, 2026 | Friday | News
Bio-Thera Solutions Initiates Phase I Trial of CD25-Targeting ADC BAT8013 in Advanced Solid Tumors

Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, announced that dosing has begun in a Phase 1 clinical study evaluating B...

July 27, 2026 | Monday | News
ArkBio Completes Healthy Volunteer Dosing in Phase I Trial of Long-Acting Influenza Candidate AK0406

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced that all cohorts of healthy volunteers have been dosed in an Australian Phase I trial with AK...

July 27, 2026 | Monday | News
Argo Biopharma Doses First Participant in Phase I Trial of BW-41012

BW-41012 represents the eighth clinical candidate from Argo's innovative RNAi pipeline, and is being evaluated for the prevention of thromboembolic disea...

July 21, 2026 | Tuesday | News
Fangzhou Introduced Kyinsu® on Its AI Healthcare Platform Through Novo Nordisk Collaboration

Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, annou...

July 21, 2026 | Tuesday | News
Biocytogen Partners with Whitehawk Therapeutics to Develop Bispecific ADCs

Biocytogen  and Whitehawk Therapeutics, Inc.  announced a global collaboration to develop bispecific antibody-drug conjugates (BsADC). Biocytog...

July 09, 2026 | Thursday | News
Aligos Receives $25 Million Upfront Payment from Amoytop as Pevifoscorvir Sodium Secures Breakthrough Therapy Designation in China

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapie...

July 08, 2026 | Wednesday | News
InnoCare Doses First Patient in China Trial of Novel CDH17-Targeted ADC ICP-B208

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced to...

July 07, 2026 | Tuesday | News
Nona Biosciences and Lonza Partner to Advance Next-Generation BBB-Crossing Technology for CNS Therapies

Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, announce...

July 06, 2026 | Monday | News
Innovent and Lilly Expand China Oncology Alliance with Verzenios Commercialization Agreement

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality...

July 01, 2026 | Wednesday | News
WuXi Biologics Secures ANVISA GMP Certification for Three Wuxi Facilities, Strengthening Commercial Manufacturing for Brazil

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturin...

July 01, 2026 | Wednesday | News
Universe Pharmaceuticals to Acquire Best Praise in $10.75 Million Patent Deal

Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distribut...

June 29, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close